DoM Bridge Funding Awardees!
The talented awardees all have inspiring and innovative research areas of focus, in key areas that impact our patients’ health and well-being.
Please join us in congratulating the following people:
Dr. Karen Jacobson, Department of Medicine, Section of Infectious Disease. Dr. Jacobson’s expertise is in studying tuberculosis transmission and outcomes. Dr. Jacobson’s research, which spans national and global work, has a particular emphasis on understanding how substance use impacts on tuberculosis transmission and response to therapy.
Dr. Naomi Ko, Department of Medicine, Section of Hematology-Oncology. Dr. Ko’s research has a translational focus directed to understanding the disconnect between scientific discoveries in cancer treatment and delivery of evidence-based treatment to marginalized, racial/ethnic minority women with breast cancer. She is actively investigating how tumor biology, poverty, communication and treatment influence breast cancer outcomes in diverse breast cancer populations.
Dr. Maureen Dubreuil, Department of Medicine, Section of Rheumatology. Dr. Dubreuil’s research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. (note: Dr. Dubreuil’s bridge funding award is co-funded by BMC and the Department of Medicine)
Dr. Emily Hurstak, Department of Medicine, Section of General Internal Medicine. Dr. Hurstack’s conducts clinical research around improving outpatient systems of care for patients who have been economically and socially marginalized, with a focus on individuals with substance use disorders (SUD) and chronic pain syndromes. Dr. Hurstak participates in both clinical care and research with a focus on health communication, health literacy, and improving care for patients with SUDs in primary care settings.
Dr. Titi Ilori, Department of Medicine, Section of Nephrology. Dr. Ilori’s research includes mechanistic and interventional studies on the etiologic factors and modifiers of chronic kidney disease (CKD), with a special emphasis on the effect of diet (dietary nutrients and dietary patterns), biomarkers, and genetics on CKD progression in both low resource and high-income countries. Her current work is in gene by environment interactions in APOL1 nephropathy and her lab recently discovered that dietary potassium interacts with the APOL1 genotypes.